ruxolitinib’s role in treating myelofibrosis
Published 5 years ago • 65 plays • Length 6:08Download video MP4
Download video MP3
Similar videos
-
9:29
ruxolitinib’s role in treating myelofibrosis
-
2:22
dr. scherber discusses ruxolitinib failure in myelofibrosis
-
8:38
the use of ruxolitinib in myelofibrosis
-
1:42
dr. mesa on ruxolitinib vs fedratinib in myelofibrosis treatment
-
1:46
dr. snyder on ruxolitinib in patients with myelofibrosis
-
1:10
dr. bradley on the utility of ruxolitinib in myelofibrosis and polycythemia vera
-
1:49
dr. kuykendall on the impact of ruxolitinib in myeloproliferative neoplasms
-
4:17
pv: treatment with ruxolitinib
-
5:54
treating intermediate/high-risk primary myelofibrosis
-
2:10
management of ruxolitinib failure in myelofibrosis
-
7:43
the role of fedratinib in myelofibrosis
-
1:52
the role of ruxolitinib in the treatment of early-stage myelofibrosis
-
1:15
reviewing the role and efficacy of ruxolitinib in myelofibrosis ten years after its approval
-
1:48
dr. scherber on the treatment of myelofibrosis
-
1:53
selinexor in myelofibrosis treatment
-
2:30
dr. harrison on 5-year follow-up data on ruxolitinib in patients with myelofibrosis
-
2:07
real-world use of ruxolitinib in patients with myelofibrosis with anemia or thrombocytopenia
-
2:14
ruxolitinib combinations in patients with myelofibrosis
-
2:12
navtemadlin and its role in the treatment of r/r myelofibrosis